Universal Health Realty Income Trust vs Chiron Real Estate
UHT and XRN side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How UHT and XRN compare
Universal Health Realty Income Trust is the larger company, worth 1.5 times as much as Chiron Real Estate ($540M against $355M).
On earnings, Chiron Real Estate is cheaper: it trades at 7.7× trailing earnings, against 26.8× for Universal Health Realty Income Trust.
Chiron Real Estate grew revenue faster over the last twelve months (8.0% versus −0.02% for Universal Health Realty Income Trust).
Both pay dividends: Universal Health Realty Income Trust yields 7.7% and Chiron Real Estate 8.0%.
Universal Health Realty Income Trust scores higher on the StockData Score (16 against 10 for Chiron Real Estate), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | UHT | XRN |
|---|---|---|
| Size and price | ||
| Market cap | $540M | $355M |
| Share price | $38.86 | $26.79 |
| Change, 1 year | −1.5% | −16.9% |
| Change, 5 years | −33.2% | −67.5% |
| Beta (5Y) | 0.56 | 0.85 |
| Employees | – | 30 |
| StockData Score | ||
| Total score | 16 (better) | 10 |
| Valuation score | 3 | 5 (better) |
| Growth score | 1 | 1 |
| Performance score | 3 (better) | 0 |
| Health score | 5 (better) | 0 |
| Dividend score | 4 | 4 |
| Valuation | ||
| P/E | 26.8× | 7.7× (better) |
| P/S | 5.4× | 2.3× (better) |
| P/B | 3.9× | 0.5× (better) |
| EV/EBITDA | 8.4× | – |
| Fair value | $40.06 | $100.51 |
| Margin of safety | 3.0% | 73.3% (better) |
| Growth | ||
| Revenue growth (TTM) | −0.02% | 8.0% (better) |
| Revenue growth, 5Y average | 4.9% | 9.6% (better) |
| Net income growth (TTM) | 12.4% | – |
| EPS growth (TTM) | 12.4% | – |
| EPS growth, 5Y average | −2.1% | – |
| Profitability | ||
| Operating margin | 35.9% | – |
| Net margin | 20.3% | – |
| Return on equity | 13.5% | – |
| Return on invested capital | 19.8% | – |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Altman Z-score | 3.27 (better) | 0.09 |
| Piotroski F-score | 5 | – |
| Dividends and buybacks | ||
| Dividend yield | 7.7% | 8.0% (better) |
| Payout ratio | 206% | – |
| Years of dividend growth | 15 | – |
| Dividend growth, 5Y average | 1.4% | – |
| Shareholder yield | 7.7% | 8.0% (better) |
| Ownership | ||
| Held by institutions | 62.0% | 75.2% |
| Held by insiders | 2.7% | 2.3% |
| Insider net buying, 12 months | $0 | $3.5M (better) |
| Short interest, % of float | 2.1% | 7.3% |
Go deeper
- UHT stock overview
- UHT income statement
- UHT valuation and score
- XRN stock overview
- XRN income statement
- XRN valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.